Literature DB >> 15523347

Determinants of quality of life in patients with psoriasis: a study from the US population.

Joel M Gelfand1, Steven R Feldman, Robert S Stern, John Thomas, Tara Rolstad, David J Margolis.   

Abstract

BACKGROUND: Psoriasis is a common disease with substantial effects on quality of life. Few quality of life studies have been performed in psoriasis patients from the general US population.
OBJECTIVE: To describe the determinants of quality of life in psoriasis patients from the US population.
METHODS: Patients were randomly selected from the US population. Patients who identified themselves as having been diagnosed with psoriasis by a physician were invited to complete a more detailed survey about quality of life.
RESULTS: Two hundred sixty-six psoriasis patients from the US population completed the detailed survey. Body surface area showed the strongest association with decrements in quality of life (Spearman 0.50, P < .0001). Younger patients and female patients also had statistically significant reductions in quality of life. Increasing psoriasis severity was associated with seeking care from multiple physicians and having decrements in income.
CONCLUSION: Patients with more extensive skin involvement have greater reductions in quality of life. Female patients and young patients are affected to a greater extent.

Entities:  

Mesh:

Year:  2004        PMID: 15523347     DOI: 10.1016/j.jaad.2004.04.014

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  69 in total

Review 1.  Assessing long-term drug safety: lessons (re) learned from raptiva.

Authors:  Nicole M Seminara; Joel M Gelfand
Journal:  Semin Cutan Med Surg       Date:  2010-03

2.  Smoking and the risk of psoriasis in women: Nurses' Health Study II.

Authors:  Arathi R Setty; Gary Curhan; Hyon K Choi
Journal:  Am J Med       Date:  2007-11       Impact factor: 4.965

Review 3.  Is there truly a risk of lymphoma from biologic therapies?

Authors:  Erica Dommasch; Joel M Gelfand
Journal:  Dermatol Ther       Date:  2009 Sep-Oct       Impact factor: 2.851

4.  Psoriasis: correlation between severity index (PASI) and quality of life index (DLQI) in patients assessed before and after systemic treatment.

Authors:  Maria Flávia Pereira da Silva; Maria Rita Parise Fortes; Luciane Donida Bartoli Miot; Silvio Alencar Marques
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

Review 5.  The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Erica D Dommasch; Katrina Abuabara; Daniel B Shin; Josephine Nguyen; Andrea B Troxel; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2011-02-18       Impact factor: 11.527

Review 6.  Non-alcoholic fatty liver disease and psoriasis: So far, so near.

Authors:  Giulia Ganzetti; Anna Campanati; Annamaria Offidani
Journal:  World J Hepatol       Date:  2015-03-27

7.  Risk of depression in women with psoriasis: a cohort study.

Authors:  E D Dommasch; T Li; O I Okereke; Y Li; A A Qureshi; E Cho
Journal:  Br J Dermatol       Date:  2015-09-24       Impact factor: 9.302

8.  Cutaneous microdialysis: cytokine evidence for altered innate reactivity in the skin of psoriasis patients?

Authors:  Florence Sjögren; Karin Davidsson; Michael Sjöström; Chris D Anderson
Journal:  AAPS J       Date:  2012-02-29       Impact factor: 4.009

9.  Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis.

Authors:  E D Dommasch; D B Shin; A B Troxel; D J Margolis; J M Gelfand
Journal:  Br J Dermatol       Date:  2009-11-10       Impact factor: 9.302

10.  Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.